Release Date: 03/11/14 08:24 Summary: Quarterly Reports - September 2014 Price Sensitive: Yes Download Document 216.42KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%